Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Huang, Y. Wang, W. Wang (Nanjing, China). Study on mechanism of resistance in Acinetobacter baumannii to quinolones. Eur Respir J 2009; 34: Suppl. 53, 2427

Member's Comments

No comment yet.

Related content which might interest you: Drug resistance patterns in patients with multi-drug resistant tuberculosis (MDR – TB) Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012 Detection of mutations associated with isoniazid and rifampicin resistance in M. tuberculosis isolates from Kazakhstan Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010 Treatment of difficult Gram-positive infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=113 Year: 2004 Minimal inhibitory concentrations (MICs) of mefloquine: in vitro activity against MDR- and nonMDR-Tb strains Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB Source: Eur Respir J 2009; 33: 581-585 Year: 2009 Multidrug resistant pulmonary TB: Characteristics of drug resistance profiles of MBT in Ukraine Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 Characterisation and prevalence of macrolide resistance Streptococcus pneumoniae infecting pediatric patients Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood Year: 2009 The effect on imipenem on the regulation of ampC and oprD genes in Pseudomonas biofilm Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Aminoglycoside ototoxicity monitoring in multidrug resistant tuberculosis: How much is enough? Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment Year: 2012 The resistome and other mechanisms of antibiotic resistance Source: International Congress 2015 – Antibiotic resistance in respiratory infections Year: 2015 Long-term, low-dose azithromycin treatment reduces the prevalence of staphylococcus aureus, but selects for macrolide resistance in Danish CF-patients Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007 Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones}, Source: Eur Respir J 2012; 40: 814-822 Year: 2012 Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Trends of MBT drug resistance Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Antibiotic resistance and clinical outcomes: the CAPNETZ experience Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis Source: Eur Respir J , 49 (4)  1700173; DOI: 10.1183/13993003.00173-2017 Year: 2017 Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis Source: Eur Respir J , 49 (4)  1700317; DOI: 10.1183/13993003.00317-2017 Year: 2017 A multicenter study of antimicrobial resistance of clinical strains of pneumococci in Kyrgyzstan Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Unit of multidrug resistant tuberculosis - effect of treatment Source: Eur Respir J 2002; 20: Suppl. 38, 614s Year: 2002